Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-63

Generally speaking, yes you are right. I work in a public hospital in a clinical and administrative capacity. When there is urgency (eg covid, bed block blah blah blah), quick decisions can be made and technology adopted in less time, and at significant expenditure. A paid trial in an outpatient clinic should be well within the realm of possibility here imo. We are not talking adoption on a statewide level yet, so costs are negligible when compared to health budgets. My anticipation and concern is there probably wasn't a fight or counterargument put up by the company. There certainly should have been an agreement and announcement for revenue to commence at the end of the next gratis period, assuming the clinic chooses to continue its use. For crying out loud, are they actually trying to make money!?! We could be the first not for profit on the asx!